<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFB6A546-016B-4320-B731-A2461A684571"><gtr:id>AFB6A546-016B-4320-B731-A2461A684571</gtr:id><gtr:name>University of Wollongong</gtr:name><gtr:address><gtr:line4>Wollongong</gtr:line4><gtr:line5>NSW 2522</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E777F7E-8B7E-406A-87FB-39A7026F891F"><gtr:id>4E777F7E-8B7E-406A-87FB-39A7026F891F</gtr:id><gtr:name>Uppsala University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFB6A546-016B-4320-B731-A2461A684571"><gtr:id>AFB6A546-016B-4320-B731-A2461A684571</gtr:id><gtr:name>University of Wollongong</gtr:name><gtr:address><gtr:line4>Wollongong</gtr:line4><gtr:line5>NSW 2522</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBCB742D-FE66-4CF5-AB44-6B86B53865C4"><gtr:id>EBCB742D-FE66-4CF5-AB44-6B86B53865C4</gtr:id><gtr:firstName>Damian</gtr:firstName><gtr:surname>Crowther</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FC10C2F9-6E9D-47E2-9489-AA868B49F0B4"><gtr:id>FC10C2F9-6E9D-47E2-9489-AA868B49F0B4</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lomas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/451729D7-E9B5-453F-9312-7D41BE427A77"><gtr:id>451729D7-E9B5-453F-9312-7D41BE427A77</gtr:id><gtr:firstName>Michele</gtr:firstName><gtr:surname>Vendruscolo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D099FFE8-DF94-462F-8B16-B943AA467BFC"><gtr:id>D099FFE8-DF94-462F-8B16-B943AA467BFC</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Dobson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700990"><gtr:id>0D1D9E0E-1626-4FF8-82FB-495DA3B3F4DD</gtr:id><gtr:title>The molecular determinants of the aggregation and toxicity of peptides and proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700990</gtr:grantReference><gtr:abstractText>Proteins are the building blocks of human cells and they direct the wide range of chemical reactions that are needed by a living creature. However proteins also cause a range of diseases, mostly those that affect the brains of older people, such as Alzheimer?s, Parkinson?s and motor neurone disease. In these disorders proteins stick together and become lodged in tissues, such as the brain, causing damage. We have looked at how proteins stick together in experiments that we carry out in test tubes and we have developed a computer program that can tell in advance how sticky a particular protein will be. Our recent work has shown that this program can also tell us how toxic a protein will be if it is introduced into the brain of a fruit fly. Although the fly brain is small there are many similarities with the human brain. We expect that by understanding exactly what makes a protein sticky and toxic in the fly brain we will be able to stop the same processes in the human brain. We might be able to do this by developing medicines that change the way proteins stick together to make them harmless.</gtr:abstractText><gtr:technicalSummary>This proposal brings together a group of people with a wide range of skills from the Departments of Chemistry, Physics, Nanoscience, Genetics and Medicine to investigate the fundamental causes of a range of diseases that are caused by protein misfolding and aggregation. Our project is based on three key advances that have occurred in Cambridge, the first is the understanding that the potential to form amyloid fibrils is a common, if not fundamental, property of all proteins. The second is the discovery that we can accurately predict the aggregation propensity of proteins knowing only their amino acid sequences. The third advance has been the development of Drosophila models of protein aggregation diseases. We will focus on understanding the fundamental mechanisms that underlie a range of protein misfolding disorders and use our range of skills to carefully observe protein aggregation in the test tube, interpret the data using sophisticated computer algorithms and use Drosophila model systems to provide further insights into pathological significance. We will extend our preliminary studies on the Abeta peptide and investigate other proteins implicated in neurological disorders and so formulate a quantitative model that describes the molecular determinants of peptide and protein aggregation and toxicity. Such a powerful understanding of fundamental disease mechanisms will provide us with new opportunities and strategies for therapeutic intervention.</gtr:technicalSummary><gtr:fund><gtr:end>2013-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1533529</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Functional Genomics Unit</gtr:department><gtr:description>Human, worm and fly screening</gtr:description><gtr:id>DEC88037-C228-4B74-8C41-7BA70E2C34A3</gtr:id><gtr:impact>We have a review in TIBS in press and we are co-organising a mini-symposium at ICAD2010, an international Alzheimer's disease meeting.</gtr:impact><gtr:outcomeId>FFEA8AD5E1E-1</gtr:outcomeId><gtr:partnerContribution>Introduced the group to worm models of protein misfolding diseases</gtr:partnerContribution><gtr:piContribution>I wrote the grant and mentored the postdoc who is working on the project. My group will host the fly work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Comparative &amp; Clinical Anatomy (CCCA)</gtr:department><gtr:description>Cambridge University Neurodegeneration Consortium</gtr:description><gtr:id>2B5D0906-29CD-4FBC-A438-0AFF32638E12</gtr:id><gtr:impact>Industrial sponsorship has been attracted.</gtr:impact><gtr:outcomeId>JibH2uFChXn-1</gtr:outcomeId><gtr:partnerContribution>The consortium has a series of collaborative meetings where we share data and discuss ongoing collaboration.</gtr:partnerContribution><gtr:piContribution>This substantial grant was awarded to Prof. Peter St.George-Hyslop by MRC/Wellcome Trust. My groups role is to interface between the theoretical chemists who are expert in the molecular mechanisms of protein folding and misfolding and neuroscience. In particular we use Drosophila model systems to bridge the disciplinary gap.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wollongong</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Role of extracellular chaperones in Alzheimer's disease</gtr:description><gtr:id>4DB82997-91EF-43BF-96D2-D1CED28B39A9</gtr:id><gtr:impact>paper under review looking at the generic mechanism of protein aggregate toxicity.</gtr:impact><gtr:outcomeId>06B5997ABC3-1</gtr:outcomeId><gtr:partnerContribution>We have hosted a postdoctoral fellow who worked on in vitro and in vivo models of protein misfolding diseases. This has resulted in a paper that is currently under review.</gtr:partnerContribution><gtr:piContribution>I have co-ordinated the work of two postdoctoral fellows and liased with the University of Wollongong. The work has consisted of in vitro, biophysical work, and in vivo experiments using our Drosophila model systems.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uppsala University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Stabilising alpha helical structure to prevent amyloid formation</gtr:description><gtr:id>4818D0D7-5A74-4CF8-B61F-A5BBDBD295A3</gtr:id><gtr:impact>16849336 19458258</gtr:impact><gtr:outcomeId>FDBAA814704-1</gtr:outcomeId><gtr:partnerContribution>A graduate student is working in my lab looking at the ability of an extracellular chaperone to modulate Abeta toxicity in our fly model system.</gtr:partnerContribution><gtr:piContribution>I supervise the PhD student and am working to write a postdoctoral fellowship.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Websites</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5D728BA-69B6-40A1-98D8-93B0445656A6</gtr:id><gtr:impact>Various websites contributed to: www.gpnotebook.co.uk http://www.neuroscience.cam.ac.uk/directory/profile.php?damiancrowther http://web.me.com/damiancrowther/Site/Welcome.html

Publicity and explanation of our work for the public: http://web.me.com/damiancrowther/Site/FAQ.html</gtr:impact><gtr:outcomeId>DB94B4F76BE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local TV news interview about research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F5189BAE-DEAF-45F8-953B-D3A7EC495FEB</gtr:id><gtr:impact>I was interviewed for about 2 min in an article about Alzheimer's disease on the local TV news (Look East).

I got positive feedback from the public and from the Alzheimer's research trust who organised the interview.</gtr:impact><gtr:outcomeId>TsH4boWzNcz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D1769CEE-18BB-4E15-AA29-AD00FCA2D5D6</gtr:id><gtr:impact>Was interviewed on Radio Cambridgeshire about the work on Alzheimer's disease.

Publicity.</gtr:impact><gtr:outcomeId>C93CA5DB13B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4295F352-D850-4105-8931-94D405A60380</gtr:id><gtr:impact>We had an exhibition of our work using flies as models of neurodegeneration in the department of Chemistry in Cambridge.

Publicity and communication.</gtr:impact><gtr:outcomeId>103CC60E318</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FF3B2D11-A902-4021-91E9-74A4BE273CFD</gtr:id><gtr:impact>Talk biannually to a local 6th form college to the medical society.

We get summer students working in the lab.</gtr:impact><gtr:outcomeId>587C4E16210</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2009,2011,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer Research UK public meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4EAA27C8-CD9E-4B17-B1B8-4B331E738CC1</gtr:id><gtr:impact>50 members of the public attended the annual meeting to hear about dementia research in clinical and basic domains.

nil</gtr:impact><gtr:outcomeId>dMfM49dkRnQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.alzheimer.group.cam.ac.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1975342</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BB/H003843/1 Quantitative approaches to defining normal and aberrant protein homeostasis</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>D8642142-1878-476C-9C8A-093A64D3241F</gtr:id><gtr:outcomeId>kTH7V1q5VZ70</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>190000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Research UK Senior Fellowship (for D.C. Crowther)</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ART-SRF2010-2</gtr:fundingRef><gtr:id>4424552B-C0AE-482C-A595-5F4F9E070AA7</gtr:id><gtr:outcomeId>EPZDBo4if9F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome/MRC Neurodegeneration initiative</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>MC_G1000734</gtr:fundingRef><gtr:id>C8C53770-AC74-462F-B40D-D5EF01C85D0B</gtr:id><gtr:outcomeId>AFB9EBA49690</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>154000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Major Research Grant</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>662AA5A9-9F09-4609-9363-63ACED7540E3</gtr:id><gtr:outcomeId>E4B0C8C8A7A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We express the human proteins and peptides in the brain of Drosophila melanogaster and see phenotypes including reduced lifespan, locomotor dysfunction and neurodegeneration.</gtr:description><gtr:id>C74C73C8-7C52-43BE-95D2-913A3A8F0C9D</gtr:id><gtr:impact>Allow investigation of a range of neurodegenerative diseases caused by protein aggregation</gtr:impact><gtr:outcomeId>071BF8CDF9A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Various other models of human neurodegenerative diseases</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We express the human Abeta peptide in the brain of Drosophila melanogaster and see phenotypes including reduced lifespan, locomotor dysfunction and neurodegeneration.</gtr:description><gtr:id>1B4864E4-924C-405F-A052-459FF7ECC52A</gtr:id><gtr:impact>Rapid in vivo model for investigating the biological relevance of in vitro theories of protein aggregation. Also good for performing genetic screens and finding pathways of disease.</gtr:impact><gtr:outcomeId>B28777C5523</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Drosophila model of Abeta toxicity in Alzheimer's disease</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>iFly is computer vision equipment and software that allows the detailed analysis of fly locomotion. This allows the very early detection of subtle deficits that accompany neurodegeneration</gtr:description><gtr:id>74E8D909-9C39-4299-8BAE-1FD8BCB1EF84</gtr:id><gtr:impact>This will greatly accelerate screening of genes and compounds for efficacy against the disease related phenotypes in the flies.</gtr:impact><gtr:outcomeId>2552357EE58</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Computer vision locomotor assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Floceleris</gtr:companyName><gtr:description>Company that is seeking commercial partners for a seeded aggregation assay that may be used for the detection of seeded aggregation in clinical samples. This may provide a test to detect the pathological processes underpinning a number of neurodegenerative disorders.</gtr:description><gtr:id>A2591F44-A8E6-4946-A7E6-984E43015954</gtr:id><gtr:impact>Winner of the Cambridge University Entrepreneurs, Carpe Diem Life Science Start-up of the Year 2013. 
Incorporated as a limited company in October 2013.</gtr:impact><gtr:outcomeId>FRhEoWW6Pay</gtr:outcomeId><gtr:url>http://www.floceleris.com/</gtr:url><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>409A183D-EB65-4AC2-B8A7-E0CAFC45D987</gtr:id><gtr:title>Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/646375eb2e08ff9def18210ac984c268"><gtr:id>646375eb2e08ff9def18210ac984c268</gtr:id><gtr:otherNames>Yanamandra K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ABF971CC468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD38517F-05EB-43D6-A7C4-318F04987E5C</gtr:id><gtr:title>Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14439_29_21147772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF13F11-506C-4147-90B8-7DF5F2933869</gtr:id><gtr:title>Prion-induced toxicity in PrP transgenic Drosophila.</gtr:title><gtr:parentPublicationTitle>Experimental and molecular pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845f10e2cfdae85b838f5d99b1815d5e"><gtr:id>845f10e2cfdae85b838f5d99b1815d5e</gtr:id><gtr:otherNames>Thackray AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-4800</gtr:issn><gtr:outcomeId>pm_14439_29_22314254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CBB2E41-914D-4928-8D53-F3216722AB95</gtr:id><gtr:title>Identification of novel modifiers of A? toxicity by transcriptomic analysis in the fruitfly.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1548e42de1ce0c557f8d289141e467c9"><gtr:id>1548e42de1ce0c557f8d289141e467c9</gtr:id><gtr:otherNames>Favrin G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>pm_540e156e156faf2c2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3F81612-D3D3-4840-AA1E-615A4D56628B</gtr:id><gtr:title>Physicochemical determinants of chaperone requirements.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/706a1fa7e50cd6deb2981206265ed35a"><gtr:id>706a1fa7e50cd6deb2981206265ed35a</gtr:id><gtr:otherNames>Tartaglia GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>YPghRqarKDk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F27B3E62-49D1-472B-BF72-01DBA7B092DC</gtr:id><gtr:title>Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14439_29_23814041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>912061BE-4471-46B3-9FC5-6222DA9D0F02</gtr:id><gtr:title>Towards quantitative predictions in cell biology using chemical properties of proteins.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1199752fc9cde7e846031cb95acd4935"><gtr:id>1199752fc9cde7e846031cb95acd4935</gtr:id><gtr:otherNames>Vendruscolo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>enoKa2eicDJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D61332D0-F692-4BD1-87BB-937FB2DC971C</gtr:id><gtr:title>Functional genomics in Drosophila models of human disease.</gtr:title><gtr:parentPublicationTitle>Briefings in functional genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdf261a22d7c6fdb5177fdf04b8c78d"><gtr:id>2bdf261a22d7c6fdb5177fdf04b8c78d</gtr:id><gtr:otherNames>Chen KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-2649</gtr:issn><gtr:outcomeId>pm_14439_29_22914042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AB7A0E1-7781-4754-A130-CEF845EE7839</gtr:id><gtr:title>Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf5edbd3f4fbad35c3ab1d019e9abc44"><gtr:id>bf5edbd3f4fbad35c3ab1d019e9abc44</gtr:id><gtr:otherNames>Kumita JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>pm_14439_29_21965601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>192C684D-6409-4371-AA04-F7EBFCBB8CBB</gtr:id><gtr:title>Alzheimer's disease: insights from Drosophila melanogaster models.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba8cd4e2666db5508690fa7f0df47407"><gtr:id>ba8cd4e2666db5508690fa7f0df47407</gtr:id><gtr:otherNames>Moloney A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>oscojh7FpT6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F58F1626-518B-4032-8E2E-B0B43712A0E8</gtr:id><gtr:title>Protein misfolding and disease: from the test tube to the organism.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a65b97c25e25c188f705a93c531fd1"><gtr:id>02a65b97c25e25c188f705a93c531fd1</gtr:id><gtr:otherNames>Luheshi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn><gtr:outcomeId>0681930A4BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA3811E0-0694-448C-9656-620AB7C5521B</gtr:id><gtr:title>ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4031368e0dfff5a4f0edaea20b575f"><gtr:id>5a4031368e0dfff5a4f0edaea20b575f</gtr:id><gtr:otherNames>Murakami T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14439_29_21949354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF1C926-D069-4C14-A91A-2959EB7456DD</gtr:id><gtr:title>Coordinate regulation of eIF2a phosphorylation by PPP1R15 and GCN2 is required during Drosophila development.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c027531dbd4f201d7cb44046a044ee"><gtr:id>f0c027531dbd4f201d7cb44046a044ee</gtr:id><gtr:otherNames>Malzer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14439_29_23418347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93BC9DA9-84B1-436E-BCBA-4D7C7121E221</gtr:id><gtr:title>Iron is a specific cofactor for distinct oxidation- and aggregation-dependent A? toxicity mechanisms in a Drosophila model.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d700f2ef80690fb6cf5c955606ad18"><gtr:id>91d700f2ef80690fb6cf5c955606ad18</gtr:id><gtr:otherNames>Ott S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>56e69cc7d35b21.40706240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60146454-5746-4358-8143-C7C4826BC935</gtr:id><gtr:title>Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c027531dbd4f201d7cb44046a044ee"><gtr:id>f0c027531dbd4f201d7cb44046a044ee</gtr:id><gtr:otherNames>Malzer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>RNBzb8skevh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9A0E55A-4391-4CE6-95A4-CE76C50952FB</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546334ad315b56.70070914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51873087-A177-4C89-A39B-4B5D0211E3A1</gtr:id><gtr:title>alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>D197070F133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD9EB1A1-8772-4C4D-ACDD-6FD3C832EEC9</gtr:id><gtr:title>p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stress.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce2846dbc3dd405f1e8fe7efc22c044"><gtr:id>8ce2846dbc3dd405f1e8fe7efc22c044</gtr:id><gtr:otherNames>Thomas SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14439_29_23341460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ACA4480-33C4-4FA4-8D90-C4684EE50D49</gtr:id><gtr:title>Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c43b777939003fa62f7990a0cf0c1961"><gtr:id>c43b777939003fa62f7990a0cf0c1961</gtr:id><gtr:otherNames>Pechmann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>964787A3AD1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72D3F4B0-F10C-420F-AED4-A6F76172CB35</gtr:id><gtr:title>The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with A?.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9541c253264314e5eb20a3324142288"><gtr:id>c9541c253264314e5eb20a3324142288</gtr:id><gtr:otherNames>Lim JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56e69ce7691c86.51037392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FF5A72D-9754-43E5-8DF1-2EBA2BE590F7</gtr:id><gtr:title>Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e38e486731c929953d5e646e4801bba"><gtr:id>2e38e486731c929953d5e646e4801bba</gtr:id><gtr:otherNames>Jahn TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>pm_14439_29_21315762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB17D00-1442-4D2D-A0B6-CE9147D20DA6</gtr:id><gtr:title>Oligomer-targeting with a conformational antibody fragment promotes toxicity in A?-expressing flies.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2546796fc2c8d73b2dded20b7225fb51"><gtr:id>2546796fc2c8d73b2dded20b7225fb51</gtr:id><gtr:otherNames>Wacker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>546334ad6ad999.27728058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08401FC0-1CC1-4924-8F43-9D0465F0B345</gtr:id><gtr:title>ANS binding reveals common features of cytotoxic amyloid species.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/746d3abf532cca8c27056c28330ea61e"><gtr:id>746d3abf532cca8c27056c28330ea61e</gtr:id><gtr:otherNames>Bolognesi B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>ePTk1Wsy4g9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A1DA11-35AD-40EE-9E97-1445AB1AA14A</gtr:id><gtr:title>Structural dynamics associated with intermediate formation in an archetypal conformational disease.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05ef27b40b42c70c0c49913ddaf4a28e"><gtr:id>05ef27b40b42c70c0c49913ddaf4a28e</gtr:id><gtr:otherNames>Nyon MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_14439_29_22405009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8EA1C60-58CC-4820-986A-2758774BD9E9</gtr:id><gtr:title>Insights into amyloid disease from fly models.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdf261a22d7c6fdb5177fdf04b8c78d"><gtr:id>2bdf261a22d7c6fdb5177fdf04b8c78d</gtr:id><gtr:otherNames>Chen KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>546334ad01d578.36494512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>304810C2-3AA3-48B1-AAA2-45366C86F423</gtr:id><gtr:title>Suppression of A? toxicity by puromycin-sensitive aminopeptidase is independent of its proteolytic activity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d13cbfa1c2e17b03d7503e9b907759f"><gtr:id>2d13cbfa1c2e17b03d7503e9b907759f</gtr:id><gtr:otherNames>Kruppa AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_14439_29_23911349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>745A5244-1D0E-4D77-ABF9-CB7BDE6731C7</gtr:id><gtr:title>Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c313a04789d028c61a004f008f6b5233"><gtr:id>c313a04789d028c61a004f008f6b5233</gtr:id><gtr:otherNames>Sandberg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>ZwT1PqaqWQJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F0534E-B8CC-4272-B3FD-424035736BBB</gtr:id><gtr:title>The chaperone domain BRICHOS prevents CNS toxicity of amyloid-? peptide in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f2ab4fb00ee0196e8a790036e19df51"><gtr:id>4f2ab4fb00ee0196e8a790036e19df51</gtr:id><gtr:otherNames>Hermansson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_540e157e15712eebf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46886506-01D4-4A61-8787-C8BEC52E9D37</gtr:id><gtr:title>Drosophila melanogaster as a Model for Studies on the Early Stages of Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9541c253264314e5eb20a3324142288"><gtr:id>c9541c253264314e5eb20a3324142288</gtr:id><gtr:otherNames>Lim JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5675e9ae8c9a6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40A5C930-60E5-4B88-83A7-2E2E3F3D353D</gtr:id><gtr:title>Expression of the alternative oxidase mitigates beta-amyloid production and toxicity in model systems.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73400bee143fb812db66c09f93585101"><gtr:id>73400bee143fb812db66c09f93585101</gtr:id><gtr:otherNames>El-Khoury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>582305ee681ed0.89173761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8776F3F6-51ED-447B-9B4E-CFFF973C990B</gtr:id><gtr:title>Replacing the axial ligand tyrosine 75 or its hydrogen bond partner histidine 83 minimally affects hemin acquisition by the hemophore HasAp from Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21516f8594ab8fcefa69749781793efe"><gtr:id>21516f8594ab8fcefa69749781793efe</gtr:id><gtr:otherNames>Kumar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>585d59ec6e5df1.29335013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAB155FF-B704-4471-B0DB-03E0BB976E93</gtr:id><gtr:title>Endoplasmic reticulum dysfunction in neurological disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14439_29_23237905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93857F24-2288-47E3-A1F8-8DD77D8B293C</gtr:id><gtr:title>Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/706a1fa7e50cd6deb2981206265ed35a"><gtr:id>706a1fa7e50cd6deb2981206265ed35a</gtr:id><gtr:otherNames>Tartaglia GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>3370F93EC44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42947B7F-CFB9-491A-BD73-20249391B5F5</gtr:id><gtr:title>Characterisation of serpin polymers in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12261156b163aa7165a4fc782edd347"><gtr:id>a12261156b163aa7165a4fc782edd347</gtr:id><gtr:otherNames>Belorgey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>pm_14439_29_21115126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>713DF6F6-C56B-42D7-A980-682D605614BA</gtr:id><gtr:title>Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8196b7176ccf1c65220a9f39a4c79fb8"><gtr:id>8196b7176ccf1c65220a9f39a4c79fb8</gtr:id><gtr:otherNames>Rival T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>A5F265CBC78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D15FC34A-5CEA-4897-AAF9-53D26D34BA28</gtr:id><gtr:title>The serpinopathies studying serpin polymerization in vivo.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_14439_29_22078544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86839308-E0C5-4079-8182-97331B8ECB46</gtr:id><gtr:title>Ovine PrP transgenic Drosophila show reduced locomotor activity and decreased survival.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845f10e2cfdae85b838f5d99b1815d5e"><gtr:id>845f10e2cfdae85b838f5d99b1815d5e</gtr:id><gtr:otherNames>Thackray AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14439_29_22435640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B824B249-1A17-4526-A72F-C2B886875569</gtr:id><gtr:title>Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Drug design, development and therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1177-8881</gtr:issn><gtr:outcomeId>pm_14439_29_21966212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B699F76A-D87D-4369-B056-2EC2BEE8DA20</gtr:id><gtr:title>Proteome-level interplay between folding and aggregation propensities of proteins.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/706a1fa7e50cd6deb2981206265ed35a"><gtr:id>706a1fa7e50cd6deb2981206265ed35a</gtr:id><gtr:otherNames>Tartaglia GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pkcohrtnzjZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A0893AE-E042-4548-9F6D-27B8468FBD9B</gtr:id><gtr:title>Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5e899a850cc40ef7cf5d905e476ba2"><gtr:id>8f5e899a850cc40ef7cf5d905e476ba2</gtr:id><gtr:otherNames>Costa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14439_29_21998304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DF5CBDC-6F7F-4BE6-9632-952E8C2CBCF4</gtr:id><gtr:title>Methods and models in neurodegenerative and systemic protein aggregation diseases.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience (Landmark edition)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c3f8b913c0f1c26cb10f35a40d4a9be"><gtr:id>0c3f8b913c0f1c26cb10f35a40d4a9be</gtr:id><gtr:otherNames>Brorsson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1093-4715</gtr:issn><gtr:outcomeId>YGvMwJXoQdH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A35960-B559-4E29-867A-8D47F84660CA</gtr:id><gtr:title>Alpha-1 antitrypsin deficiency</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ef39b61a478d5fe425ead15fb4df587"><gtr:id>6ef39b61a478d5fe425ead15fb4df587</gtr:id><gtr:otherNames>Lomas, D.A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>9780470572702</gtr:isbn><gtr:outcomeId>Zb163DmCJ2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04468EB4-2046-495E-9C50-325F55C2CC30</gtr:id><gtr:title>Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c3f8b913c0f1c26cb10f35a40d4a9be"><gtr:id>0c3f8b913c0f1c26cb10f35a40d4a9be</gtr:id><gtr:otherNames>Brorsson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>iuo75jN4ryV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56E744B1-A6DA-49A1-88F7-FBA4C8AEEBC9</gtr:id><gtr:title>Defining the mechanism of polymerization in the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14439_29_20855577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FE24092-E288-41C2-AEF3-C6C37615E83F</gtr:id><gtr:title>The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77022d2c91419c4674e064367803e5db"><gtr:id>77022d2c91419c4674e064367803e5db</gtr:id><gtr:otherNames>Kohlhoff KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>pm_14439_29_21698336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B75C039-D92E-449D-AEB0-1E3DFA7CE4EE</gtr:id><gtr:title>Expression in drosophila of tandem amyloid ? peptides provides insights into links between aggregation and neurotoxicity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/135678b9cdb3619b7a2d6bd080589f43"><gtr:id>135678b9cdb3619b7a2d6bd080589f43</gtr:id><gtr:otherNames>Speretta E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14439_29_22461632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47D795E0-D1D0-4393-AD36-54223A37AE50</gtr:id><gtr:title>The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6499f68ace8d7e6a2eeae99a83daf6"><gtr:id>ef6499f68ace8d7e6a2eeae99a83daf6</gtr:id><gtr:otherNames>Miranda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>9669F6CE414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75B2D2BF-EC44-40DA-88B7-DA6138648A68</gtr:id><gtr:title>Unravelling the twists and turns of the serpinopathies.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_14439_29_21624056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9BABC69-3A20-4F12-ACF8-140018EFBEC4</gtr:id><gtr:title>Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a275f6dc84f36fec5937aed4ea02da1"><gtr:id>0a275f6dc84f36fec5937aed4ea02da1</gtr:id><gtr:otherNames>Kroeger H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>38B5F957100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F5E370B-EA42-44E8-B7A0-F3C6E7747275</gtr:id><gtr:title>Alpha-helix targeting reduces amyloid-beta peptide toxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b5e243007b016cd917a432ada05fd7b"><gtr:id>5b5e243007b016cd917a432ada05fd7b</gtr:id><gtr:otherNames>Nerelius C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>ED641BF63A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E34FE0F-EFDD-40C3-90CF-EE8662FEE040</gtr:id><gtr:title>The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1af6a7aa2b6eb07c70cf4f56e724f4c1"><gtr:id>1af6a7aa2b6eb07c70cf4f56e724f4c1</gtr:id><gtr:otherNames>Gregory JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14439_29_22384095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CF7DB46-FA80-425A-A9C5-FF53D5A97ED4</gtr:id><gtr:title>Retro-inversal of intracellular selected ?-amyloid-interacting peptides: implications for a novel Alzheimer's disease treatment.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4613bc86c6b58f4e8bd4b42403f9b762"><gtr:id>4613bc86c6b58f4e8bd4b42403f9b762</gtr:id><gtr:otherNames>Acerra N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>546334ad920868.58451659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65AE1911-46D3-494B-B5E6-EC6AC074FA0D</gtr:id><gtr:title>Using a Drosophila model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>SEB experimental biology series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fae788d36b173a228a158d9f2f13e221"><gtr:id>fae788d36b173a228a158d9f2f13e221</gtr:id><gtr:otherNames>Crowther DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1946-4959</gtr:issn><gtr:outcomeId>2367D4F6861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACEB6C9-BBCE-4FEB-B33A-B7F9DD5340A4</gtr:id><gtr:title>Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85c262d94342bca702dffd6483191b72"><gtr:id>85c262d94342bca702dffd6483191b72</gtr:id><gtr:otherNames>Chiou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>pm_14439_19_19843463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F26C6D81-539A-4910-811D-664FC08C7B6B</gtr:id><gtr:title>Position-dependent electrostatic protection against protein aggregation.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41e28ad45f63b11e57e4bed174a7ddcb"><gtr:id>41e28ad45f63b11e57e4bed174a7ddcb</gtr:id><gtr:otherNames>Buell AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>3E6AA625417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8B3E502-D11E-4DAF-8DA7-5C462B0BE984</gtr:id><gtr:title>Bridging the gap: from protein misfolding to protein misfolding diseases.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a65b97c25e25c188f705a93c531fd1"><gtr:id>02a65b97c25e25c188f705a93c531fd1</gtr:id><gtr:otherNames>Luheshi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>E51A648F040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCE51CEC-5F07-4F43-8864-A269BCCA152F</gtr:id><gtr:title>Methods in protein biochemistry</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ef39b61a478d5fe425ead15fb4df587"><gtr:id>6ef39b61a478d5fe425ead15fb4df587</gtr:id><gtr:otherNames>Lomas, D.A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-3-11-025233-0</gtr:isbn><gtr:outcomeId>CTntanMb4W1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70B2D0E3-0D50-4F9B-BF5F-D4B5B4DEF9A5</gtr:id><gtr:title>Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a65b97c25e25c188f705a93c531fd1"><gtr:id>02a65b97c25e25c188f705a93c531fd1</gtr:id><gtr:otherNames>Luheshi LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>PYV4D9PHQFK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F6E80F9-AE39-4B33-9B2C-D2E00864C7AA</gtr:id><gtr:title>Modeling serpin conformational diseases in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e38e486731c929953d5e646e4801bba"><gtr:id>2e38e486731c929953d5e646e4801bba</gtr:id><gtr:otherNames>Jahn TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_14439_29_21683257</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700990</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>